The AMD variant rs181705462 was associated with higher C4 peptide levels for all four C4 peptides, of which C4 peptide 17 showed the strongest effect (B = 1.713, SE = 0.401, p-value = 2.55 × 10−5, PFDR = 0.001). This evidence concerns the gene C4A and age-related macular degeneration.